Anzeige
Mehr »
Login
Mittwoch, 15.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Löst diese riesige Entdeckung die Kupferkrise der KI? So ändert sich die Rechnung durch diesen Explorer!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2P75D | ISIN: US57667L1070 | Ticker-Symbol: 4MGN
Tradegate
15.01.25
16:58 Uhr
31,250 Euro
+0,470
+1,53 %
Branche
Internet
Aktienmarkt
S&P 500
1-Jahres-Chart
MATCH GROUP INC Chart 1 Jahr
5-Tage-Chart
MATCH GROUP INC 5-Tage-Chart
RealtimeGeldBriefZeit
31,24531,30017:14
31,25031,30517:14
PR Newswire
218 Leser
Artikel bewerten:
(1)

Flo Health UK Limited: Former Match Group CEO Mandy Ginsberg Joins Flo Health's Board of Directors

Finanznachrichten News

Ms. Ginsberg's demonstrated leadership and extensive experience in consumer technology will support Flo's strategic growth

LONDON, Jan. 15, 2025 /PRNewswire/ -- Flo Health ("Flo"), the #1 women's health app worldwide1 with 73 million monthly active users2 and the first European femtech to be valued at over one billion USD3, today announced the appointment of former Match Group CEO Mandy Ginsberg to its Board of Directors, effective immediately. Ms. Ginsberg's extensive experience in consumer technology and her demonstrated leadership in scaling successful brands make her a valuable addition to Flo's Board of Directors as the company focuses on continued strategic expansion globally.

Flo Health logo

Ms. Ginsberg brings over 20 years of experience building category-defining consumer brands in the technology sector to the Flo Board. Throughout her 14-year career at Match Group, she held several executive positions at the company in North America, ultimately serving as CEO from 2017 to 2020. During Ms. Ginsberg's tenure, Match Group expanded its portfolio from a single brand - Match.com - operating in North America, to more than 12 brands with users across every country in the world. As CEO, she managed renowned brands such as Hinge, Tinder, OkCupid and international brands including Meetic in Europe and Pairs in Japan. During her tenure as CEO, she drove subscriber and revenue growth and quadrupled Match Group's stock price.

In her role on Flo's Board, Ms. Ginsberg will utilize her experience supporting technology companies through periods of expansion to prepare Flo for its next stage of business growth, with a focus on sustainable momentum, effective governance, and enhanced market visibility.

Dmitry Gurski, CEO of Flo, expressed his enthusiasm for Ms. Ginsberg's appointment. "We couldn't be more excited to welcome Mandy to our Board. Her extensive experience in consumer technology and her demonstrated ability to scale businesses will be vital as we embark on our next phase of growth. We look forward to leveraging her expertise to help us further our mission of creating a better future for female health."

"I am thrilled to join Flo Health's Board of Directors," said Ms. Ginsberg. "Flo's commitment to empowering women through health and wellness resonates deeply with me, especially as a mom of two daughters. The team at Flo has created an incredible product built on technology acumen, a growth mentality, and an expert medical team supporting a robust portfolio of interactive reproductive health content. I am thrilled to collaborate with Dmitry and the executive team at Flo to drive meaningful change in women's health."

Jessie Cai, Principal at General Atlantic and member of Flo's Board, commented, "We are excited to welcome Mandy to the Flo Board of Directors. Mandy's personal passion for empowering women through health and wellness, combined with her track record in building and advising global consumer internet and subscription businesses, will support Flo in tackling the big opportunities ahead."

Ms. Ginsberg is currently an operating partner at Advent International, a global private equity investment firm. She currently serves on the Boards of Directors at Uber Technologies, ThredUp, and Universal Music Group, and previously served as a director at Match Group, J.C. Penney Company, Care.com, and Noom. Ms. Ginsberg holds a BA from the University of California, Berkeley and an MBA from The Wharton School of the University of Pennsylvania. She lives in Dallas, TX with her family including two daughters - a high school student and a medical student at The University of Texas.

Flo Health
Flo Health is the leading app in the Health & Fitness category4; it is the #1 OB-GYN-recommended app5 for period and cycle tracking and is the first European femtech unicorn following a 230M investment from General Atlantic in July 2024. The company supports 73 million monthly active users (MAUs) and 6 million paid subscribers.6 With over 120 medical experts7, Flo is committed to supporting women at every stage of their health journey, from menstruation to conception, pregnancy, and menopause. It provides curated cycle and ovulation tracking, tailored health insights, daily bite-sized visual content, and a private community for users to share their questions and concerns. As part of its mission to build a better future for female health, Flo's Pass it on Project aims to improve health literacy by providing up to 1 billion women in need with free access to Flo Premium and has donated 20M subscriptions to date. Flo prioritizes safety and focuses on being the most trusted digital source for women's health information. Flo Health's Anonymous Mode feature was recognized as one of TIME's Best Inventions 2023 and also named a finalist for Fast Company's 2023 World Changing Ideas Awards in the Rapid Response category as part of the company's commitment to privacy. For more information, please visit https://flo.health.

Media Contact:
Flo Health
Denae Thibault
d_thibault@flo.health









1 Sensor Tower, December '24, iOS & Android, by downloads

2As of December 31, 2024

3"Flo Health Unicorn Raise News." Sifted, July 30, 2024. https://sifted.eu/articles/flo-health-unicorn-raise-news

4 Sensor Tower, December '24, iOS & Android, by downloads

5 Survey of 500 US OB-GYNs, DRG ('21)

6 As of December 31, 2024

7 As of December 31, 2024

Logo - https://mma.prnewswire.com/media/2598047/Flo_Health_UK_Limited__Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/former-match-group-ceo-mandy-ginsberg-joins-flo-healths-board-of-directors-302351078.html

© 2025 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.